{
    "organizations": [],
    "uuid": "38344a6e0051568aa8e70f2205e6053914ec7ae6",
    "author": "",
    "url": "https://www.reuters.com/article/brief-protalix-biotherapeutics-pegunigal/brief-protalix-biotherapeutics-pegunigalsidase-alfa-receives-fast-track-designation-from-fda-idUSASB0C37I",
    "ord_in_thread": 0,
    "title": "BRIEF-Protalix Biotherapeutics' Pegunigalsidase Alfa Receives Fast Track Designation From FDA",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 31, 2018 / 12:39 PM / in 22 minutes BRIEF-Protalix Biotherapeutics' Pegunigalsidase Alfa Receives Fast Track Designation From FDA Reuters Staff 1 Min Read \nJan 31 (Reuters) - Protalix Biotherapeutics Inc: \n* PROTALIX BIOTHERAPEUTICSâ€™ PEGUNIGALSIDASE ALFA RECEIVES FAST TRACK DESIGNATION FROM THE U.S. FOOD AND DRUG ADMINISTRATION Source text for Eikon: Further company coverage:",
    "published": "2018-01-31T14:38:00.000+02:00",
    "crawled": "2018-01-31T15:08:13.020+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "pm",
        "minute",
        "biotherapeutics",
        "pegunigalsidase",
        "alfa",
        "receives",
        "fast",
        "track",
        "designation",
        "fda",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "protalix",
        "biotherapeutics",
        "inc",
        "protalix",
        "biotherapeutics",
        "pegunigalsidase",
        "alfa",
        "receives",
        "fast",
        "track",
        "designation",
        "food",
        "drug",
        "administration",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}